Walter and Eliza Hall Institute researchers have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are…
Tag: virus
VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines
PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN® (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts (EGWs), has been added as a…
Profectus BioSciences commences GENEVAX IL-12 phase 1 study for HIV
Profectus BioSciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, and the AIDS Clinical Trials Group (ACTG) announced today the initiation of a phase…
Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the New England Journal of Medicine has published results from TARGET 1 and TARGET 2, the Company’s two pivotal Phase 3 efficacy and safety studies of…
Dongsheng obtains exclusive sales rights of Thymosin Alpha 1 Injection in China
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has obtained the exclusive sales rights of Thymosin Alpha 1 Injection in 19 provinces in China from Shanghai Biochemistry Pharmaceutical Co. I. The…
Two doses of varicella vaccine provide higher antibody levels than one
When vaccinating children against varicella (chicken pox), researchers at Yale School of Medicine have found, two doses are better than one. In fact, the odds of developing chicken pox were 95 percent…
Get examined during Glaucoma Awareness Month
It happens slowly. Over time, a person’s vision will get worse. Until one day, that person can no longer see. Glaucoma is the second leading cause of blindness in the United States…
FDA lifts clinical hold on Hemispherx’s Alferon LDO Phase II study for influenza prevention
Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the “Company” or “Hemispherx”) announced today that the Food and Drug Administration (FDA) has lifted a clinical hold on its Phase II, double-blind, adaptive-design, randomized, placebo-controlled, dose-ranging…
Flu outbreak peak yet to come
Parents of kids returning to school in the UK after Christmas holidays have been warned of a surge in flu cases. Professor John Oxford, a leading virologist at St Bartholomew’s and the…
Trial to eliminate deadly Dengue begins
The 12 week programme costing $18 million named ‘Eliminate Dengue’ has commenced. Mosquitoes bearing a special bacteria would be released into the wild around Cairns as part of a trial to rid…
C. difficile infection has become common among hospitalized children in the US
Hospitalized children in the United States are more frequently becoming infected with the bacteria Clostridium difficile, according to a report posted online today that will appear in the May print issue of…
AHF to supply $1 million in free AIDS drugs to Florida’s disenrolled and wait listed HIV/AIDS patients
As the State of Florida grapples with a budget shortfall that has crippled its AIDS Drug Assistance Program (ADAP) and forced the state to potentially disenroll 350 Florida patients already on ADAP…
ImmuVen to develop T cell receptor proteins for treating MRSA, cancer
Start-up company ImmuVen and the University of Illinois Urbana-Champaign have entered into a license agreement under which ImmuVen will develop modified T cell receptor proteins for the purpose of treating cancer and…
FDA approves 200 mg formulation of INTELENCE for HIV-1
The U.S. Food and Drug Administration (FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human…
Quantum mechanics technique against flu
With the current outbreak of the flu season in Israel, hospitals are reporting overcrowding, and doctors are advising people who have not yet been vaccinated against flu to get their shots. Surprisingly,…